Theramx Inc. news
Theramx, `Skinstitch LLC` of the United States, and `PT. Prima Centra Medika citra` of Indonesia.
It was announced on the 4th that it had completed a distribution supply contract.
`EG-Q Bond`, a bioadhesive for epidermal bonding, released through research and development by Theramx, is a medical device that joins the skin without the use of a separate suture. It compensates for the
Theramx Corporation announced on the 18th that it would promote the listing on KONEX with the will to properly evaluate the company`s value through listing on the occasion of the completion of the recent export of `EG-Q` to Europe.
Theramx, which has a GMP production facility in Seongnam, Gyeonggi-do and its own research center in Uiwang, Gyeonggi-do, is focusing on developing a nano-bio material-based drug delivery (D
<
